Technology Behind Gemelli Biotech’s Trio-Smart® Used in New Study Linking Intestinal Sulfide Overproduction to a Distinct Small-Bowel Gene-Expression Signature
Exploratory research in mSystems finds broader small-bowel gene-expression changes in ISO than in methanogen overgrowth or culture-defined bacterial overgrowth, with each condition showing a distinct profile, supporting the biological rationale for distinguishing them
MESA, Ariz., October 30, 2026--A new peer-reviewed study in mSystems, a journal of the American Society for Microbiology, finds that intestinal sulfide overproduction (ISO) is associated with a distinct gene-expression signature in the small bowel, one that looks markedly different from two related conditions commonly grouped with ISO.
ISO, small intestinal bacterial overgrowth (SIBO), and intestinal methanogen overgrowth (IMO) are microbial imbalances closely tied to irritable bowel syndrome (IBS), which affects an estimated 6.1% of U.S. adults yet remains widely underdiagnosed. In this study, researchers classified ISO and IMO from fasting breath samples, measuring hydrogen sulfide and methane, respectively, and classified SIBO using duodenal aspirate culture. Until now, no study had compared how gene activity in patients' own intestinal cells differs across the three conditions.
Led by researchers at the MAST Program at Cedars-Sinai, with breath gases measured using proprietary gas chromatography by Gemelli Biotech, the study analyzed small-bowel biopsies from 85 participants undergoing upper gastrointestinal endoscopy, measuring which genes were more or less active in their intestinal cells.
The findings point to three biologically distinct conditions. Among patients who had only one of the three, no differentially expressed gene was shared across all three groups, and pairwise overlap was minimal. ISO, associated with elevated hydrogen sulfide, showed by far the broadest changes, involving genes associated with energy production, oxidative balance, immune signaling, and intestinal fluid regulation and transit, a pattern with potential relevance to mechanisms associated with diarrhea-predominant IBS. IMO and SIBO were associated with substantially fewer gene-expression changes in this group. In animal experiments, rats exposed to some hydrogen-sulfide-producing bacteria showed partially concordant changes, while a non-producing strain did not show the same broad ISO-associated pattern.
Because their symptoms overlap, the three conditions can be hard to tell apart clinically. The study suggests that treating them as biologically interchangeable may overlook meaningful differences. The study's breath measurements were performed using Gemelli Biotech's gas chromatography technology, the same technology that enables its Trio-Smart breath test to detect hydrogen sulfide. For Gemelli, the findings add peer-reviewed support to the scientific rationale for distinguishing these conditions.